NorthCoast Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,195
| Closed | -$402K | – | 421 |
|
|
2020
Q4 | $402K | Sell |
4,195
-2,732
| -39% | -$262K | 0.02% | 280 |
|
|
2020
Q3 | $666K | Buy |
6,927
+267
| +4% | +$25.7K | 0.03% | 223 |
|
|
2020
Q2 | $813K | Sell |
6,660
-1,362
| -17% | -$166K | 0.05% | 186 |
|
|
2020
Q1 | $694K | Buy |
+8,022
| New | +$694K | 0.04% | 183 |
|
|
2018
Q4 | – | Sell |
-180,397
| Closed | -$22.2M | – | 254 |
|
|
2018
Q3 | $22.2M | Buy |
+180,397
| New | +$22.2M | 1.37% | 26 |
|